Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02190344
Other study ID # 019-2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2014
Est. completion date June 2016

Study information

Verified date April 2019
Source Sunnybrook Health Sciences Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to determine the functionality of an eight-channel paddle coil system which is to be used in future MRI studies.


Description:

Prostate cancer is the most common malignancy among men and the second leading cause of cancer death in men. Currently, MRI is the best imaging modality for both detecting prostate cancer and determining the presence of extra-prostatic extension. Multiparametric Magnetic Resonance, combining T2-weighted, diffusion-weighted and dynamic contrast enhanced imaging (DCE-MRI) is recommended as the minimum acceptable standard for prostate MRI examination. However, MPMRI still lacks diagnostic accuracy in the transition zone, where distinguishing cancer from proliferative nodules has proven difficult. DCE-MRI techniques evaluate the time course of signal intensities after administration of a contrast medium and have been used to successfully differentiate benign from malignant tumours, particularly in breast and prostate cancer. Unfortunately, current DCE approaches have high false-positive rates and are limited in distinguishing prostatitis and vascularized BPH nodules from cancer in active surveillance studies. Future studies that employ spectroscopic MR imaging of the prostate after administration of Hyperpolarized (13C) Pyruvate Injection, are expected to provide a robust, non-invasive method to assist in detecting and characterizing prostate cancer. The objective of this study is to determine the functionality of an eight-channel paddle coil system which is to be used in future Hyperpolarized (13C) Pyruvate Injection studies.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Healthy male volunteers between 18 and 80 years of age

Exclusion Criteria:

- Any contra-indication for MR imaging (such as pacemakers, surgical implants, foreign metal objects in the body)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
8-channel paddle coil
MRI Coil

Locations

Country Name City State
Canada Sunnybrook Health Sciences Centre Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Sunnybrook Health Sciences Centre Ontario Institute for Cancer Research

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability of Coil to produce MRI images functional with adequate SNR
functional with non-adequate SNR
non-functional
1 hour